Aptamer based fluorescent probe for serum HER2-ECD detection: The clinical utility in breast cancer

HB5 aptamer-based probe have been developed for serum HER2-ECD test in auxiliary clinical diagnosis and treatment for HER2-positive breast cancer patients.